UTA Family 3 Final EXAM (2025/2026) Updated: EXAM QUESTIONS WITH ACCURATE ANSWERS | GET IT RIGHT!!

UTA Family 3 Final EXAM (2025/2026) Updated:
EXAM QUESTIONS WITH ACCURATE ANSWERS |
GET IT RIGHT!!

Save




Terms in this set (112)


2017 ACC/AHA guidelines: <120 / <80
normal BP

2017 ACC/AHA guidelines: 120-129/ <80
elevated BP

2017 ACC/AHA guidelines: 130--89
stage 1 HTN

2017 ACC/AHA guidelines: ≥ 140/ ≥ 90
stage 2 HTN

What is recommended for - lifestyle modification
white coat hypertension? - annual ABPM or HBPM

What is recommended for - lifestyle modification
masked hypertension? - start HTN medication

What is recommended for - lifestyle modification
elevated BP? - annual ABPM

- drug resistant/induced hypertension
What is secondary - exacerbation of previously controlled hypertension
hypertension? - accelerated/malignant hypertension
- unprovoked or excessive hypokalemia

, - renal disease
What are common causes
- aldosteronism
of secondary
- OSA
hypertension?
- drug and alcohol induced

- weight loss
What are non-
- DASH diet
pharmacological
- sodium reduction
interventions for
- potassium supplementation
hypertension?
- reduce alcohol consumption

2017 ACC/AHA guidelines: use BP lowering meds
clinical CVD and BP ≥ 130
/ ≥ 80

2017 ACC/AHA guidelines: use BP lowering meds
primary prevention in
adults 10 yr ASCVD risk of
≥ 10%

2017 ACC/AHA guidelines: use BP lowering meds
10 yr risk < 10% and SBP ≥
140/90

2017 ACC/AHA guidelines: yearly
normal BP reassessment

2017 ACC/AHA guidelines: 3-6 months
elevated BP reassessment

2017 ACC/AHA guidelines: 3-6 months
stage 1 HTN reassessment
and 10 yr ASCVD < 10%

2017 ACC/AHA guidelines: one month until goal BP met, then 3-6 months
stage 2 HTN reassessment

2017 ACC/AHA guidelines: one month until BP goal met, then 3-6 months
stage 1 HTN reassessment
and 10 yr ASCVD > 10%